• 01 Pipeline Progress
• 02 Technology Platform
• 03 Research Areas

Creating Value Through Innovation

Stable Cash Flow Supports The Innovation Pipeline

Pursuit of excellence, striving to make good medicines available sooner

Pipeline Progress

• Bogutai®
• UOS003
• Uni-GLP-1
• UDS003
• UB101/UB102
• UB104
• Fibronectin
• Beauty peptides
• Collagen
• Microecological skin-care
• Stem cell exosome
• Diquafosol sodium eye drop

Explore more

Formulation Integration Platform

Ensuring Fast Return-On-Investment

Integration and optimization, throughout the whole cycle, the pursuit of establishing a high-quality platform system

Technology Platform

• New Drug Research Platform
• Clinical Development Platform
• Production & Quality Platform
• Commercialization Platform

Explore more

Four-Wheel Drive

Focus On Multiple Critical Disease Areas

Differentiated layout, directly hit the pain points, capture the strong market potential

Research Areas

• Endocrinology (diabetes, osteoporosis, etc.)
• Ophthalmology (corneal injury, dry eye, AMD, DME, etc.)
• Skin care (wound healing, medical aesthetic advanced raw materials, etc.)

Explore more

Creating Value Through Innovation

Stable Cash Flow Supports The Innovation Pipeline

Pursuit of excellence, striving to make good medicines available sooner

Pipeline Progress

• 1、Bogutai®
• 2、UOS003
• 3、Uni-GLP-1
• 4、UDS003
• 5、UB101/UB102
• 6、UB104
• 7、Fibronectin
• 8、Beauty peptides
• 9、Collagen
• 10、Microecological skin-care
• 11、Stem cell exosome
• 12、Diquafosol sodium eye drop

Explore more

Formulation Integration Platform

Ensuring Fast Return-On-Investment

Integration and optimization, throughout the whole cycle, the pursuit of establishing a high-quality platform system

Technology Platform

• 1、New Drug Research Platform
• 2、Clinical Development Platform
• 3、Production & Quality Platform
• 4、Commercialization Platform

Explore more

Four-Wheel Drive

Focus On Multiple Critical Disease Areas

Differentiated layout, directly hit the pain points, capture the strong market potential

Research Areas

• 1、Endocrinology (diabetes, osteoporosis, etc.)
  2、Ophthalmology (corneal injury, dry eye, AMD, DME, etc.)
  3、Skin care (wound healing, medical aesthetic advanced raw materials, etc.)

Explore more

Caring, Responsible, Leading, Focused

Follow our promise “Leading genuine innovation”

Uni-Bio Science is committed to improving the quality of life of patients through innovative therapies and is built upon the vision of addressing the pressing needs in the provision of high-quality Chinese healthcare solutions, and has achieved several major milestones with its product portfolio and experienced commercial function.

2023-08-29

Uni-Bio Science 2023 Interim Results，Achieved Record High Profit of HK$39.4M

Uni-Bio Science 2023 Interim Results，Achieved Record High Profit of HK$39.4M，Driven by Scale-Up Operations and Remarkable Growth in Marketed Drugs，Expanding Multiple Channels and Diverse Commercialization for New Products

See More

2023-03-28

Uni-Bio Science Announces 2022 Annual Results，Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved Expanding Portfolio with New Drug Innovations and Strategic R&D Partnerships

Uni-Bio Science Announces 2022 Annual Results，Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved Expanding Portfolio with New Drug Innovations and Strategic R&D Partnerships

See More

2023-03-13

The four-pillar cultivates new growth engines for high-quality development | Uni-Bio Science Group's 2023 Annual Strategy Conference was successfully held

From February 23, Uni-Bio Science Group's 2023 Annual Strategy Conference was held in Beijing, attended by the Chairman, CEO, heads and colleagues of the BU.

See More

2023-03-01

Join hands together and Build up a head of steam | Uni-Bio Science Group's 2023 Annual Marketing Conference was successfully held

From February 15 to 17, Uni-Bio Science Group's 2023 Annual Marketing Conference was held in Xiamen, attended by the Chairman and CEO of Uni-Bio and all front-line marketing backbones from all units across the country. Embarking on a new journey, many new

See More